EMICIZUMAB PROPHYLAXIS IN HAEMOPHILIA A WITH AND WITHOUT INHIBITORS: REAL-WORLD DATA FROM SLOVENIA

被引：0
|
作者：
Rener, K. [1 ]
Doma, S. Anzej [1 ]
Kotnik, B. Faganel [2 ]
Kitanovski, L. [2 ]
Fink, M. [1 ]
Zupan, I. Preloznik [1 ]
机构：
[1] Univ Med Ctr Ljubljana, Haematol, Ljubljana, Slovenia
[2] Div Paediat, Haematol, Ljubljana, Slovenia
来源：
HAEMOPHILIA | 2021年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ABS096
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [1] Real-world data on the use of emicizumab in patients with haemophilia A with and without inhibitors in Singapore
    Lee, Ming Wei
    Cheong, May Anne
    Ng, Heng Joo
    Tien, Sim Leng
    Lam, Joyce Ching Mei
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2023, 52 (11) : 580 - 589
  • [2] INVASIVE PROCEDURES IN PATIENTS WITH HAEMOPHILIA ON EMICIZUMAB PROPHYLAXIS: REAL-WORLD CLINICAL EXPERIENCE IN SLOVENIA
    Rener, K.
    Pompe, B.
    Doma, S. Anzej
    Kotnik, B. Faganel
    Kitanovski, L.
    Zupan, I. Preloznik
    [J]. HAEMOPHILIA, 2022, 28 : 66 - 66
  • [3] REAL-WORLD EFFICACY OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH SEVERE HAEMOPHILIA A WITHOUT INHIBITORS: A REPORT FROM THE UK HAEMOPHILIA CENTRE DOCTORS' ORGANISATION
    Wall, C.
    Xiang, H.
    Palmer, B.
    Collins, P. W.
    Stephensen, D.
    Scott, M.
    Chalmers, E.
    Chowdary, P.
    Hall, G. W.
    Liesner, R.
    Hart, D. P.
    Shapiro, S.
    Talks, K.
    Fletcher, S.
    Hay, C. R.
    [J]. HAEMOPHILIA, 2021, 27 : 116 - 116
  • [4] Real-world experience with the use of emicizumab in paediatric haemophilia A patients with and without inhibitors
    Lam, Joyce Ching Mei
    Lim, Chiew Ying
    Kadir, Nur Insyirah Abdul
    [J]. HAEMOPHILIA, 2022, 28 : 50 - 51
  • [5] Real-world experience on the tolerability and safety of emicizumab prophylaxis in paediatric patients with severe haemophilia A with and without FVIII inhibitors
    Hassan, Eman
    Jonathan, Lancashire
    Jayashree, Motwani
    [J]. HAEMOPHILIA, 2021, 27 (06) : E698 - E703
  • [6] Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors
    Ebbert, Patrick T.
    Xavier, Frederico
    Seaman, Craig D.
    Ragni, Margaret V.
    [J]. HAEMOPHILIA, 2020, 26 (01) : 41 - 46
  • [7] REAL-WORLD SAFETY AND EFFICACY OF EMICIZUMAB IN HAEMOPHILIA A WITH INHIBITORS IN THE UK
    Wall, C.
    Hall, G.
    Scott, M.
    Collins, P. W.
    Maclean, R.
    Xiang, H.
    Hay, C. R.
    Hart, D. P.
    Anderson, J.
    Dolan, G.
    Symington, E.
    [J]. HAEMOPHILIA, 2020, 26 : 64 - 65
  • [8] Real-world experience of emicizumab prophylaxis in young children with haemophilia A in China: retrospective data from China
    Huang, Kun
    Liu, Guoqing
    Wu, Runhui
    Chen, Zhenping
    Zhen, Yingzi
    Wu, Xinyi
    [J]. HAEMOPHILIA, 2022, 28 : 50 - 50
  • [9] Emicizumab prophylaxis in infants with severe haemophilia A without inhibitors: Illustrative real-world cases to support shared decision-making
    Mason, Jane A.
    Young, Guy
    [J]. HAEMOPHILIA, 2021, 27 (05) : 724 - 729
  • [10] Real-world data for the use of emicizumab in haemophilia A patients with inhibitors - First nationwide report from Korea
    Hahn, Seung Min
    Han, Jung Woo
    Kim, Jin Seok
    Shim, Ye Jee
    Kim, Soyon
    Kim, Hugh Chul
    Park, Young Shil
    Lyu, Chuhl Joo
    [J]. HAEMOPHILIA, 2023, 29 (04) : 1163 - 1166
12345